|
Research at Brown shows "signs of steady progress"
One of Brown's big research successes this year was the
University's collaboration with URI and other institutions to secure Rhode
Island's participation in the Experimental Program to Stimulate Competitive
Research (EPSCoR), a grant-making program of the National Science Foundation.
The George Street Journal visited with Andries van Dam, vice president for
research, to talk about that development and others.
Today is the second anniversary of your tenure as vice
president for research. What have those years brought?
There are noticeable signposts of steady progress, although
progress has been way slower than an impatient person like me would like to
have seen by now. We have a fully functional office and beautiful new quarters
in Horace Mann that meet our needs. Faculty come to us for help in
ever-increasing numbers. We've distributed some new sources of money to support
research and have started seeing some results from such seed funds.
 But the big change is that we have a much larger footprint
in the state than when I started. Becoming part of NSF's EPSCoR program is by
far the most important, for three reasons. First, URI and Brown got a $200,000
planning grant. That allowed us to set up a planning infrastructure led by URI
and Brown. Second, by becoming an EPSCoR state, our researchers now have access
to an additional pot of NSF money available for meritorious, peer-reviewed
proposals. Third, the planning process led to an unprecedented collaboration
among all the institutions of higher learning in the state, and between them
and the state's Economic Development organizations. This summer we submitted a
large EPSCoR (RI)2: Research Innovation for Rhode Island proposal in marine life sciences which, if awarded,
will have a major impact on life science research infrastructure in the state.
Now our researchers can also participate in a version of
this for the Department of Defense, called DEPSCoR. Same kind of thing - a
special set-aside pool of DoD money for highly meritorious, peer-reviewed
science. The NIH has such a program too.
Congress's whole intent was to give the little guys a chance
to catch up, states that had been receiving less than 1 percent of an agency's
annual research funding - but the awards are based on merit.
One of your original goals was to offer seed money to
faculty who were developing research proposals.
The seed funds for new and large-scale multidisciplinary
efforts are the most adventurous, the most high-risk/high-potential-payoff
funds in our portfolio. So far, we have had 10 start-up projects we've seeded
and we are making rounds of all of them this fall. Two have been very
successful already. One helped secure a $5-million grant to support the V.A.
Medical Center's collaboration with Brown on limb loss, and another helped
secure a grant to EpiVax for development of a tularemia vaccine in which Brown
will be significantly involved.
What we want to see out of those seed-fund grants are
multidisciplinary center-style proposals for external funding. The process of
priming the pump to help researchers write more proposals is working. A little
lubrication goes a long way.
 Where do you see that paying off?
I think there is much more team building, particularly across
departmental and divisional lines. We see many more teams from the physical
sciences and bio-med. The pace of multidisciplinary group forming is heating
up. That's responsive to national funding agendas and is absolutely what we
want to have happen.
A critically important vacancy is our assistant vice
president for research initiatives. We are looking for candidates with a
research background who would like to help other faculty with team building,
idea generation, proposal development. We're all doing that work; we just can't
do it at the pace I'd like to see. Having an AVP would make an
order-of-magnitude difference.
It's hard not to notice the degree to which the life
sciences are part of these interdisciplinary teams.
There's a major trend toward collaboration between the life
sciences and the physical sciences. There is so much intellectual foment and
excitement there and, not coincidentally, that's where significant research
funding exists. One example that I think will be hugely successful is the biosafety
aspects of nanomaterials. Investigators in bio-med are teaming with those from
engineering. They want to know what carbon nanotubes might do to cells. Nanostructures could be a huge benefit
in the body but we know far too little about potential health risks.
 Aren't the life sciences converting too? Some research
programs already seem halfway to computer science or engineering or applied
math.
Exactly. Systems biology, structural biology ... all these
have moved away from observation and experimentation to computer modeling, deep
understanding of chemistry and physics and material properties at all scales.
So yes, the life sciences are working closely with the physical scientists and
collaborating on extraordinary new tools, especially modeling and imaging
techniques.
What else?
The revised patent policy we've been working on for nine
months is ready for a third level of broad consultation. After wide review by
the faculty and administration, I hope it will go to the Corporation this
academic year. We wanted a policy that a) was more in line with what our
research peers were doing, and b) made an explicit allocation not only to the
inventor but also to the inventor's lab. The percentages are changing; there
will be more income for the inventor and the inventor's lab.
How about conditions on the outside?
I'm very concerned about funding trends in this country. The
trend lines are down. The rate of increase at NIH has slowed hugely albeit
after multiple years of significant increases. NSF has been asked to prepare a
budget cut of 3 percent. Homeland Security has a lot of money, but it's for
deployment, not long-term basic science. Department of Energy and NASA programs could come under siege. We are
the seventh-largest university for NASA funding, so a cut there could really
hurt us. I think this may come to a head in the early winter, past the election
when there are likely to be revised estimates about the size of the budget
deficit. We may have serious budget cuts proposed, and then we'll have to see
how many of our elected officials will stand up for protecting research
funding, which I believe is vital to our country's continued safety and
prosperity. Even the life science people are finding it difficult to get new
grants and there have been published reports about life scientists dropping out
of academe because of the amount of effort required to keep research and labs
funded.
And going forward?
Our mission at Brown is to make sure that the quality and
quantity of our research proposals are such that we will be among the winners
in the game. Many of our centers are going up against competitors that can
field much bigger teams. Our office exists to help our faculty compete. We want
to get more than our fair share.
If there is one thing I have learned from my two years in
this position, it is the extraordinary quality of Brown's faculty, and the
amazing research that goes on across the campus. It is really exiting to see the intellectual leadership that
our faculty and students provide and the frontier problems they are
addressing.
|